rhPSMA-7.3 (18F) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: radiohybrid PSMA-targeted PET imaging agent, Radioligand for PET CT scanning

Filter by location:

Bala-Cynwyd, Pennsylvania1 trial

Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management

MidLantic Urology

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.